Rhythm Pharmaceuticals Inc (RYTM)
59.03
-0.33
(-0.56%)
USD |
NASDAQ |
Nov 21, 16:00
61.00
+1.97
(+3.34%)
After-Hours: 05:46
Rhythm Pharmaceuticals Gross Profit Margin (Quarterly): 88.49% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.49% |
| June 30, 2024 | 89.87% |
| March 31, 2024 | 89.19% |
| December 31, 2023 | 86.66% |
| September 30, 2023 | 89.28% |
| June 30, 2023 | 88.37% |
| March 31, 2023 | 87.61% |
| December 31, 2022 | 88.30% |
| Date | Value |
|---|---|
| September 30, 2022 | 88.40% |
| June 30, 2022 | 95.83% |
| March 31, 2022 | 84.65% |
| December 31, 2021 | 87.01% |
| September 30, 2021 | 78.40% |
| June 30, 2021 | 50.00% |
| March 31, 2021 | 88.57% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.00%
Minimum
Jun 2021
95.83%
Maximum
Jun 2022
85.38%
Average
88.37%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| TG Therapeutics Inc | 88.86% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Voyager Therapeutics Inc | -- |
| Krystal Biotech Inc | 92.03% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -209.0% |
| Return on Assets | -76.55% |
| Return on Invested Capital | -209.0% |
| Profit Margin (Quarterly) | -131.2% |
| Operating Margin (Quarterly) | -132.0% |
| Return on Net Operating Assets | -705.3% |